Stocks and InvestingStocks and Investing
Fri, June 25, 2021
Thu, June 24, 2021
Wed, June 23, 2021
Tue, June 22, 2021
Mon, June 21, 2021
Sun, June 20, 2021
Fri, June 18, 2021
Thu, June 17, 2021
Wed, June 16, 2021

Jonathan Wolleben Maintained (ALT) at Buy with Increased Target to $53 on, Jun 16th, 2021


Published on 2024-10-27 17:00:00 - WOPRAI, Jonathan Wolleben
  Print publication without navigation


Jonathan Wolleben of JMP Securities, Maintained "Altimmune, Inc." (ALT) at Buy with Increased Target from $45 to $53 on, Jun 16th, 2021.

Jonathan has made no other calls on ALT in the last 4 months.



There is 1 other peer that has a rating on ALT. Out of the 1 peers that are also analyzing ALT, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Patrick Trucchio of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $35 on, Wednesday, June 2nd, 2021